Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Human papillomavirus (HPV)-expressing cells are human epithelial cells, primarily basal keratinocytes, that have been infected by HPV and express viral genes, particularly the oncogenes E6 and E7. These cells are central to the pathogenesis of HPV-associated diseases, including cervical cancer and oropharyngeal squamous cell carcinoma. Persistent infection with high-risk HPVs leads to continuous expression of viral oncoproteins, resulting in altered cellular adhesion, proliferation rates, apoptosis resistance, extracellular matrix remodeling—and ultimately contribute to carcinogenesis.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Papillomavirus-expressing Cells (None).